Skip to content

The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire

Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02285023
Acronym
CU-Q2oL
Enrollment
166
Registered
2014-11-06
Start date
2014-11-30
Completion date
2015-10-31
Last updated
2019-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Urticaria

Keywords

Chronic urticaria, CU-Q2oL

Brief summary

In the majority of patients with the chronic urticaria, the etiology is unclear, leading to difficulties in treatment and high rates of recurrence. According to the International EAACI/GA2LEN/EDF/WAO Guidelines (the Dermatology Section of the European Academy of Allergology and Clinical Immunology(EAACI), the Global Allergy and Asthma European Network (GA2LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO) in Urticaria, using the Chronic Urticaria Quality of Life Questionnaire in a routine management is the key for a better treatment outcome. To translate this questionnaire into Thai is essential in our subject of interest in order to effectively apply it to local patients. The Thai-version questionnaire will encourage enhanced as well as impactful therapeutic options for Thai chronic urticaria patients.

Detailed description

1. Adaption of the Cu-Q2oL questionnaire into Thai version by using forward-backward translation that is independently performed by two bilingual translators. The original Italian version is translated into Thai by two Thai native speakers, then the study team reviews the Thai-version Cu-Q2oL questionnaire for items comprehensibility and integrates the first consensus version which re-translated into Italian by an Italian native speaker afterwards. The comparison between the backward Italian version Cu-Q2oL questionnaire and the original Cu-Q2oL is carried out to find out whether there are any misconception and mistranslation in the intermediary forward version of questionnaire. After that, the second consensus version will be tested on 15 chronic urticaria patients to detect any misunderstanding points based on patients' comments. Finally, this Thai-version of CU-Q2oL questionnaire will be used to investigate the validity, reliability, interpretability and minimal clinical important difference. 2. To investigate the validity, reliability and interpretability of Thai-version of Chronic Urticaria Quality of Life Questionaire (CU-Q2oL), the severity of chronic urticaria symptoms will be assessed by investigators and patients using the Urticaria Activity Score (UAS7), the DLQI and CU-Q2oL questionnaire.

Interventions

OTHERCU-Q2oL

The patients will be explained how to complete the Urticaria Activity Score (UAS7) form for evaluating their severity of chronic urticaria symptoms at home. At the 2nd visit, collect the 1st UAS7 assessment. Assessment the severity of chronic urticaria symptoms. The patients fill the 1st DLQI and CU-Q2oL questionnaire and get the 2nd UAS7 form and two-week appointment to follow up. At the 3th visit, collect the 2nd UAS7 assessment. Assessment the severity of chronic urticaria symptoms. The patients fill the 2nd DLQI and CU-Q2oL questionnaire.

Sponsors

University of Genua, Italy
CollaboratorOTHER
Mahidol University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years old or above * Diagnosed as chronic urticaria based on The EAACI/GA(2)LEN/EDF/WAO Guideline * Literate in Thai language and can complete the questionnaire by themselves

Exclusion criteria

* Have other active skin diseases * Have a psychiatric problem * Cannot understand the questionnaire by themselves.

Design outcomes

Primary

MeasureTime frameDescription
Cross-Cultural Validity of Thai-version CU-Q2oL4 weekCross-cultural validity is the degree to which the performance of the Thai CU-Q2oL items can adequately reflect the performance of the original CU-Q2oL items. Exploratory factor analysis was used to determine scales with proper item division of the Thai CU-Q2oL. Principal component analysis with varimax rotation was employed. An eigenvalue ≥ 1 was chosen as the criterion to retain domains. Each item was classified into the domain when loading with a domain loading ≥ 0.5.

Secondary

MeasureTime frameDescription
Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oLbaseline\- The CU-Q2oL Questionnaire is a 23-item HRQoL questionnaire. It measures three dimensions (scales) of HRQoL: domain I (sleep, leisure, concentration), domain II (symptom, eating limits), and domain III (mental status, looks, impact on life activities) The scores of domain I of CUQ2oL range between 0 and 26. The scores of domain II of CUQ2oL range between 0 and 39.The scores of domain III of CUQ2oL between 0 and 35. The minimum possible score is 0 and the maximum possible score is 100 for total scale. -The DLQI scores range from 0-30. Domain I (leisure), Domain II (symptoms and feeling), and Domain III (daily activities, work, school, and personal relationships). Meaning of DLQI Scores: 0-1 = no effect, 2-5 = small effect, 6-10 = moderate effect, 11-20 = very large effect, 21-30 = extremely large effect. The higher the score, the more quality of life is impaired for both the CUQ2oL and the DLQI.
Change in Thai CU-Q2oL Scores From Baseline for Responders and Non-Respondersbaseline and 2 weeks\- Investigate the smallest reduction in the Thai CU-Q2oL that patients recognized as a meaningful improvement.
Area Under the Curve for Thai CUQ2oL Scores in the Responder Groupbaseline and 2 weeksThe receiver operating characteristic (ROC) analysis and area under the curve (AUC) are acceptable as the units of measure for assess the ability of a questionnaire to changes in patients' health-related quality of life (HRQoL) impairment over time that represents to responsiveness to change and minimal clinical important difference (MCID). The AUC of the ROC analysis of 1, 0.9, 0.8, 0.7 and 0.5 were considered perfect, excellent, good, fair, and no better than chance, respectively.

Countries

Thailand

Participant flow

Recruitment details

Patients diagnosed as chronic idiopathic urticaria were invited to participate in the study at the Allergy clinic in the Department of Dermatology, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Participants by arm

ArmCount
Chronic Idiopathic Urticaria Patients
* Evaluation by the Urticaria Activity Score (UAS7) * Fill the DLQI and CU-Q2oL questionnaire CU-Q2oL: The patients diagnosed as chronic idiopathic urticaria will be explained how to complete the Urticaria Activity Score (UAS7) form for evaluating their severity of chronic urticaria symptoms at home. At the 2nd visit, collect the 1st UAS7 assessment. Assessment the severity of chronic urticaria symptoms. The patients fill the 1st DLQI and CU-Q2oL questionnaire and get the 2nd UAS7 form and two-week appointment to follow up. At the 3th visit, collect the 2nd UAS7 assessment. Assessment the severity of chronic urticaria symptoms. The patients fill the 2nd DLQI and CU-Q2oL questionnaire.
166
Total166

Baseline characteristics

CharacteristicChronic Idiopathic Urticaria Patients
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
166 Participants
CU-Q2OL19.91 units on a scale
STANDARD_DEVIATION 15.9
Dermatology Life Quality Index4.67 Score
STANDARD_DEVIATION 5.3
Education166 participants
Region of Enrollment
Thailand
166 participants
Sex: Female, Male
Female
131 Participants
Sex: Female, Male
Male
35 Participants
Urticaria Activity Score8.8 units on a scale
STANDARD_DEVIATION 9.6

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 166
serious
Total, serious adverse events
0 / 166

Outcome results

Primary

Cross-Cultural Validity of Thai-version CU-Q2oL

Cross-cultural validity is the degree to which the performance of the Thai CU-Q2oL items can adequately reflect the performance of the original CU-Q2oL items. Exploratory factor analysis was used to determine scales with proper item division of the Thai CU-Q2oL. Principal component analysis with varimax rotation was employed. An eigenvalue ≥ 1 was chosen as the criterion to retain domains. Each item was classified into the domain when loading with a domain loading ≥ 0.5.

Time frame: 4 week

ArmMeasureGroupValue (NUMBER)
Extraction Sums of Square Loading (% of Variance)Cross-Cultural Validity of Thai-version CU-Q2oLDomain I (item 7,8,11-14 of CUQoL)43.71 Percentage
Extraction Sums of Square Loading (% of Variance)Cross-Cultural Validity of Thai-version CU-Q2oLDomain II( Item 1-6, 9-10, 17 of CUQoL)9.41 Percentage
Extraction Sums of Square Loading (% of Variance)Cross-Cultural Validity of Thai-version CU-Q2oLDomain III (Item 15-16, 18-23 of CUQoL)7.33 Percentage
Rotation Sums of Squared Loading (% of Variance)Cross-Cultural Validity of Thai-version CU-Q2oLDomain I (item 7,8,11-14 of CUQoL)22.11 Percentage
Rotation Sums of Squared Loading (% of Variance)Cross-Cultural Validity of Thai-version CU-Q2oLDomain II( Item 1-6, 9-10, 17 of CUQoL)20.21 Percentage
Rotation Sums of Squared Loading (% of Variance)Cross-Cultural Validity of Thai-version CU-Q2oLDomain III (Item 15-16, 18-23 of CUQoL)18.13 Percentage
Comparison: Exploratory factor analysisp-value: <0.01exploratory factor analysis
Secondary

Area Under the Curve for Thai CUQ2oL Scores in the Responder Group

The receiver operating characteristic (ROC) analysis and area under the curve (AUC) are acceptable as the units of measure for assess the ability of a questionnaire to changes in patients' health-related quality of life (HRQoL) impairment over time that represents to responsiveness to change and minimal clinical important difference (MCID). The AUC of the ROC analysis of 1, 0.9, 0.8, 0.7 and 0.5 were considered perfect, excellent, good, fair, and no better than chance, respectively.

Time frame: baseline and 2 weeks

Population: Responder group

ArmMeasureValue (MEAN)
Extraction Sums of Square Loading (% of Variance)Area Under the Curve for Thai CUQ2oL Scores in the Responder Group0.90 probability
Secondary

Change in Thai CU-Q2oL Scores From Baseline for Responders and Non-Responders

\- Investigate the smallest reduction in the Thai CU-Q2oL that patients recognized as a meaningful improvement.

Time frame: baseline and 2 weeks

ArmMeasureValue (MEAN)Dispersion
Extraction Sums of Square Loading (% of Variance)Change in Thai CU-Q2oL Scores From Baseline for Responders and Non-Responders7.3 scoreStandard Deviation 9.4
Rotation Sums of Squared Loading (% of Variance)Change in Thai CU-Q2oL Scores From Baseline for Responders and Non-Responders28.4 scoreStandard Deviation 15.3
Secondary

Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oL

\- The CU-Q2oL Questionnaire is a 23-item HRQoL questionnaire. It measures three dimensions (scales) of HRQoL: domain I (sleep, leisure, concentration), domain II (symptom, eating limits), and domain III (mental status, looks, impact on life activities) The scores of domain I of CUQ2oL range between 0 and 26. The scores of domain II of CUQ2oL range between 0 and 39.The scores of domain III of CUQ2oL between 0 and 35. The minimum possible score is 0 and the maximum possible score is 100 for total scale. -The DLQI scores range from 0-30. Domain I (leisure), Domain II (symptoms and feeling), and Domain III (daily activities, work, school, and personal relationships). Meaning of DLQI Scores: 0-1 = no effect, 2-5 = small effect, 6-10 = moderate effect, 11-20 = very large effect, 21-30 = extremely large effect. The higher the score, the more quality of life is impaired for both the CUQ2oL and the DLQI.

Time frame: baseline

Population: Mean score of domain I, II, III of Thai CU-Q2oL were correlated to mean score domain I, II, III of Thai DLQI, respectively

ArmMeasureGroupValue (MEAN)Dispersion
Extraction Sums of Square Loading (% of Variance)Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oLDomain I23.19 units on a scaleStandard Deviation 21.7
Extraction Sums of Square Loading (% of Variance)Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oLDomain II19.09 units on a scaleStandard Deviation 16.6
Extraction Sums of Square Loading (% of Variance)Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oLDomain III18.37 units on a scaleStandard Deviation 17.5
Rotation Sums of Squared Loading (% of Variance)Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oLDomain I1.86 units on a scaleStandard Deviation 1.4
Rotation Sums of Squared Loading (% of Variance)Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oLDomain II1.79 units on a scaleStandard Deviation 1.5
Rotation Sums of Squared Loading (% of Variance)Mean Total Score and Domain of Thai CU-Q2oL Scores From the Thai Version to Investigate Reliability of Thai-Version CU-Q2oLDomain III1.85 units on a scaleStandard Deviation 2.5
p-value: <0.05Crohbach's alpha

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026